Curanex Pharmaceuticals (CURX) Prepaid Assets (2024 - 2025)
Curanex Pharmaceuticals' (CURX) quarterly Prepaid Assets came in at $6.3 million in Q4 2025, up 1600.18% YoY from $367865.0 in Q4 2024, and down 27.17% on a QoQ basis from $8.6 million in Q3 2025.
Curanex Pharmaceuticals (CURX) Prepaid Assets (2024 - 2025) Analysis & Trends
Curanex Pharmaceuticals (CURX) has 2 years of Prepaid Assets data on file, last reported at $6.3 million in Q4 2025.
- Quarterly Prepaid Assets rose 1600.18% year-over-year to $6.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 1600.18% YoY) and the FY2025 annual result came in at $6.3 million, up 1600.18% from the prior year.
- Prepaid Assets retreated to $6.3 million in Q4 2025, from $8.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q3 2025 to a low of $367865.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curanex Pharmaceuticals | 6.02 Mn | 1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 596,186.00 |
| Dec 31, 2024 | 367,865.00 |